Kuehne + Nagel to invest in Switzerland for pharma logistics
29/06/2017 - 12:52:00
Mayor Fredy Boeni, Klaus-Michael Kuehne, majority shareholder of Kuehne + Nagel International AG and Dr. Detlef Trefzger, CEO of Kuehne + Nagel International AG, attended the ground-breaking ceremony for the “Pharma Hub Switzerland”.
This new facility will strengthen Kuehne + Nagel’s position as one of the leading logistics service providers for Swiss and international customers in the pharma and healthcare industry.
The Pharma Hub will be part of the KN PharmaChain network, providing multimodal temperature-controlled door-to-door shipping on a global scale, enhanced visibility and traceability of the deliveries, as well as intensive and proactive risk management.
The new Kuehne + Nagel logistics facility in Möhlin will provide 16,300 m2 of logistics space, which will be used to manage approximately 46,000 pallet spaces using a warehouse system that combines manual and automatic operation. Three different temperature zones will be available for the highly sensitive products: -20 degrees, -2 to +8 degrees, plus +15 to +25 degrees. In addition, hazardous goods and narcotics can be stored in dedicated areas.
The Möhlin Pharma Hub will also focus on providing value-added services. The facility will provide end-to-end shipping and logistics services based on GxP-compliant standard.
Dr. Detlef Trefzger, CEO of Kuehne + Nagel International AG , said: “Switzerland is an important pharma location with global reach. The cutting-edge facility in Möhlin is a strategic investment in this growth sector and supports us to serve our customers even better, especially through integration with the global Kuehne + Nagel pharma network.”